1WE

(2S)-1-phenylpropan-2-amine

Find entries where: 1WE

is present as a standalone ligand in 2 entries

Find related ligands:

Chemical Component Summary
Name	(2S)-1-phenylpropan-2-amine
Synonyms	Dextroamphetamine; D-amphetamine; Dexamphetamine; Dexedrine; Dextrostat
Identifiers	(2S)-1-phenylpropan-2-amine
Formula	C₉ H₁₃ N
Molecular Weight	135.21
Type	NON-POLYMER
Isomeric SMILES	C[C@@H](Cc1ccccc1)N
InChI	InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m0/s1
InChIKey	KWTSXDURSIMDCE-QMMMGPOBSA-N

Chemical Details
Formal Charge	0
Atom Count	23
Chiral Atom Count	1
Bond Count	23
Aromatic Bond Count	6

Drug Info: DrugBank

DrugBank ID	DB01576
Name	Dextroamphetamine
Groups	approved illicit
Description	Dextroamphetamine is the dextrorotary enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder[L6010,Label].
Synonyms	d-amphetamine (S)-1-phenyl-2-aminopropane Dexamphetamine Dexamfetamina (+)-α-methylphenylethylamine (S)-(+)-β-phenylisopropylamine (S)-(+)-amphetamine (αS)-α-methylbenzeneethanamine (S)-amphetamine (S)-α-methylbenzeneethanamine Dextroamphetamine adipate Dextroamphetamine sulfate Dexanfetamina Dextroamphetamine saccharate (+)-amphetamine Dexamfetaminum (S)-1-phenyl-2-propylamine Dexamfetamine (+)-(S)-amphetamine Desamfetamina (+)-α-methylphenethylamine Dextroamphetamine
Brand Names	Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended-Release Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Dextroamphetamine SulfateExtended-Release Extended-Release Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate Dextrostat DEXEDRINE Spansule Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII Adderall Dextroamphetamine Saccharate, Amphetamine Aspartate (monohydrate), Dextroamphetamine Sulfate, Amphetamine Sulfate Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Mixed Salts of a Single Entity Amphetamine Product XR Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate ER Apo-dextroamphetamine SR Mydayis ProCentra Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate Adderall XR Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate Dexedrine Spansule Src 10mg Procentra Zenzedi Dexedrine Spansule Dextroamphetamine Dextroamphetamine Sulfate Extended-Release Dexedrine Spansule Src 15mg Dexedrine Tablets (5mg) Dextroamphetamine Sulfate PMS-dextroamphetamine Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Xelstrym Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Suflate Act Dextroamphetamine SR Dexedrine
Indication	Dextroamphetamine is indicated for the treatment of attention deficit hyperactivity disorder (ADHD).[Label]
Categories	Agents producing tachycardia Agents that produce hypertension Amines Amphetamines Central Nervous System Agents Central Nervous System Stimulants Central Nervous System Stimulation Centrally Acting Sympathomimetics Cytochrome P-450 CYP2D6 Substrates Cytochrome P-450 Substrates Dopamine Agents Dopamine Uptake Inhibitors Ethylamines Membrane Transport Modulators Nervous System Neurotransmitter Agents Neurotransmitter Uptake Inhibitors Phenethylamines Psychoanaleptics Psychostimulants, Agents Used for ADHD and Nootropics Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome Sympathomimetics
ATC-Code	N06BA02
CAS number	51-64-9

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Synaptic vesicular amine transporter	MALSELALVRWLQESRRSRKLILFIVFLALLLDNMLLTVVVPIIPSYLYS...	unknown	inducer
Sodium-dependent noradrenaline transporter	MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLLAPRD...	unknown	negative modulator
Sodium-dependent dopamine transporter	MSKSKCSVGLMSSVVAPAKEPNAVGPKEVELILVKEQNGVQLTSSTLTNP...	unknown	negative modulator
Trace amine-associated receptor 1	MMPFCHNIINISCVKNNWSNDVRASLYSLMVLIILTTLVGNLIVIVSISH...	unknown	agonist
Alpha-1B adrenergic receptor	MNPDLDTGHNTSAPAHWGELKNANFTGPNQTSSNSTLPQLDITRAISVGL...	unknown	antagonist
Alpha adrenergic receptor	MVFLSGNASDSSNCTQPPAPVNISKAILLGVILGGLILFGVLGNILVILS...	unknown	inhibitor,inducer
Cytochrome P450 2D6	MGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVD...	unknown	substrate
Primary amine oxidase	MGSPSLYSARKTTLALAVALSFAWQAPVFAHGGEAHMVPMDKTLKEFGAD...	unknown	substrate
Sodium-dependent dopamine transporter	MSKSKCSVGLMSSVVAPAKEPNAVGPKEVELILVKEQNGVQLTSSTLTNP...	unknown
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682